Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
267
267 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- EHT102Phase 21 trial
Shanghai Euhearing Therapeutics Co., Ltd · Treatment of Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)
- EIS-12656Phase 21 trial
Eisbach Bio GmbH · Advanced Solid Tumor, Homologous Recombination Deficiency, HRR Deficiency
- EP0042Phase 21 trial
Ellipses Pharma · Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes
- EPI-321Phase 21 trial
Epicrispr Biotechnologies, Inc. · Facioscapulohumeral Muscular Dystrophy
- EXG110Phase 21 trial
Guangzhou Jiayin Biotech Ltd · Fabry Disease
- GEn-1124Phase 21 trial
GEn1E Lifesciences · Respiratory Distress Syndrome, Acute
- GKL-006RTUPhase 21 trial
Beijing Gene Key Life Technology Co., Ltd · ARDS (Acute Respiratory Distress Syndrome)
- GTX-102Phase 21 trial
Ultragenyx Pharmaceutical Inc · Angelman Syndrome
- HGT-1110Recombinant human arylsulfatase APhase 21 trial
Takeda · Metachromatic Leukodystrophy (MLD)
- HM15136Phase 21 trial
Hanmi Pharmaceutical Company Limited · Congenital Hyperinsulinism
- HM15421GC1134APhase 21 trial
GC Biopharma Corp · Fabry Disesase
- ION337Phase 21 trial
Ionis Pharmaceuticals · Dravet Syndrome
- ION440Phase 21 trial
Ionis Pharmaceuticals · Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome
- IW-6463CY6463, zagociguatPhase 21 trial
Tisento Therapeutics · Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)
- JR-171lepunafuspPhase 21 trial
JCR Pharmaceuticals Co., Ltd. · Mucopolysaccharidosis I
- JR-441posnafuspPhase 21 trial
JCR Pharmaceuticals Co., Ltd. · Mucopolysaccharidosis III-A
- KRRO-121Phase 21 trial
Korro Bio, Inc. · Urea Cycle Disorders, Inborn, Urea Cycle Disorders, Ornithine Transcarbamylase (OTC) Deficiency
- lacutamabIPH4102Phase 21 trial
Innate Pharma · Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome
- LB-100Phase 21 trial
Lixte Biotechnology Holdings, Inc. · Myelodysplastic Syndromes
- MDSY-1240Phase 21 trial
Medsyn Biopharma, LLC · Triple-Negative Breast Cancer (TNBC), Gastric Cancer (GC), Gastric Cancer Adenocarcinoma Metastatic
- MK-1439APhase 21 trial
Merck & Co. · Human Immunodeficiency Virus (HIV) Infection
- MNV-201Phase 21 trial
Minovia Therapeutics Ltd. · Mitochondrial Diseases, Pearson Syndrome
- MZE782Phase 21 trial
Maze Therapeutics · Phenylketonuria (PKU)
- NBIP-01435Phase 21 trial
Neurocrine Biosciences · Congenital Adrenal Hyperplasia
- NGGT001Phase 21 trial
NGGT (Suzhou) Biotechnology Co., Ltd. · Bietti Crystalline Corneoretinal Dystrophy
- NOE-115Phase 21 trial
Noema Pharma AG · Menopause Syndrome, Menopause, Hot Flashes
- NS-050NCNP-03Phase 21 trial
NS Pharma, Inc. · Duchenne Muscular Dystrophy
- NS-229Phase 21 trial
NS Pharma, Inc. · Eosinophilic Granulomatosis With Polyangiitis, Churg-Strauss Syndrome
- OCU400Phase 21 trial
Ocugen · Retinitis Pigmentosa, Leber Congenital Amaurosis
- OpCT-001Phase 21 trial
BlueRock Therapeutics · Primary Photoreceptor Disease, Retinitis Pigmentosa (RP), Usher Syndrome
- OrticumabMLDL1278a, BI204Phase 21 trial
Abcentra · Acute Coronary Syndromes, Coronary Arterial Disease (CAD), Inflammation
- PBGM01Phase 21 trial
Gemma Biotherapeutics · GM1 Gangliosidosis, GM1 Gangliosidosis, Type I, GM1 Gangliosidosis, Type 2
- PBSS1113Phase 21 trial
Chaser Therapeutics, Inc. · Acute Myeloid Leukemia (AML), MDS (Myelodysplastic Syndrome)
- PM647aPhase 21 trial
Prime Medicine, Inc. · Alpha-1 Antitrypsin Deficiency, Alpha-1 Antitrypsin Deficiency-associated Lung Disease, Alpha-1 Antitrypsin Deficiency (AATD)
- PYC-001Phase 21 trial
PYC Therapeutics · OPA1 Gene Mutation, Autosomal Dominant Optic Atrophy, Hereditary Optic Atrophies
- QLS2319Phase 21 trial
Qilu Pharmaceutical Co., Ltd. · Cancer Cachexia, Cancer Cachexia Syndrome
- QR-1123Phase 21 trial
ProQR Therapeutics · Autosomal Dominant Retinitis Pigmentosa, Eye Diseases, Eye Diseases, Hereditary
- RenadirsenDS-5141bPhase 21 trial
Daiichi Sankyo · Duchenne Muscular Dystrophy
- RinvaterceptKER-065Phase 21 trial
Keros Therapeutics, Inc. · Duchenne Muscular Dystrophy
- RLY-2608Phase 21 trial
Relay Therapeutics, Inc. · PIK3CA-Related Overgrowth Spectrum (PROS), Lymphatic Malformations, Vascular Malformations
- RN0361Phase 21 trial
Ikaria Bioscience Pty Ltd · Hypertriglyceridemia, Familial Chylomicronemia Syndrome
- RSLV-132Phase 21 trial
Resolve Therapeutics · Primary Sjögren Syndrome
- S241656Phase 21 trial
Servier · Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome Acute Myeloid Leukemia
- S247240Phase 21 trial
Institut de Recherches Internationales Servier (I.R.I.S.) · Fragile X Syndrome (FXS)
- sabatolimabMBG453Phase 21 trial
Novartis · Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic
- SAR444836Phase 21 trial
Sanofi · Phenylketonuria
- SAR446268Phase 21 trial
Sanofi · Myotonic Dystrophy
- SCI-110Phase 21 trial
Neurothera Labs Inc. · Tourette Syndrome
- SFL-0821Phase 21 trial
Soufflé Therapeutics, Inc. · Facioscapulohumeral Muscular Dystrophy (FSHD)
- SP-420Phase 21 trial
Pharmacosmos A/S · Beta Thalassemia Major Anemia, Myelodysplastic Syndrome
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.